American International Group, Inc. Bristol Myers Squibb CO Transaction History

American International Group, Inc.

$8.5 Billion
Q3 2024

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$47.98 - $54.4 $70,338 - $79,750	-1,466 Reduced 0.28%	515,366 $27.9 Million
Q4 2023 Feb 13, 2024	SELL	$48.48 - $57.85 $1.62 Million - $1.93 Million	-33,347 Reduced 6.06%	516,832 $26.5 Million
Q3 2023 Nov 13, 2023	SELL	$57.89 - $64.73 $712,625 - $796,826	-12,310 Reduced 2.19%	550,179 $31.9 Million
Q2 2023 Aug 04, 2023	BUY	$63.71 - $70.74 $137,613 - $152,798	2,160 Added 0.39%	562,489 $36 Million
Q1 2023 May 12, 2023	BUY	$65.71 - $74.53 $183,856 - $208,534	2,798 Added 0.5%	560,329 $38.8 Million
Q4 2022 Feb 10, 2023	SELL	$68.48 - $81.09 $109,773 - $129,987	-1,603 Reduced 0.29%	557,531 $40.1 Million
Q3 2022 Nov 14, 2022	SELL	$0.13 - $76.84 $1,557 - $920,312	-11,977 Reduced 2.1%	559,134 $39.7 Million
Q2 2022 Aug 12, 2022	SELL	$72.62 - $79.98 $2.24 Million - $2.47 Million	-30,854 Reduced 5.13%	571,111 $44 Million
Q1 2022 May 13, 2022	SELL	$61.48 - $73.72 $1.84 Million - $2.21 Million	-29,927 Reduced 4.74%	601,965 $44 Million
Q4 2021 Feb 11, 2022	SELL	$53.63 - $62.52 $749,103 - $873,279	-13,968 Reduced 2.16%	631,892 $39.4 Million
Q3 2021 Nov 12, 2021	SELL	$59.17 - $69.31 $134 Million - $157 Million	-2,266,607 Reduced 77.82%	645,860 $38.2 Million
Q2 2021 Aug 13, 2021	SELL	$61.91 - $67.42 $15 Million - $16.4 Million	-242,860 Reduced 7.7%	2,912,467 $195 Million
Q1 2021 May 07, 2021	SELL	$59.34 - $66.74 $14.1 Million - $15.9 Million	-237,553 Reduced 7.0%	3,155,327 $199 Million
Q4 2020 Feb 12, 2021	SELL	$57.74 - $65.43 $18.1 Million - $20.5 Million	-313,776 Reduced 8.47%	3,392,880 $210 Million
Q3 2020 Nov 04, 2020	SELL	$57.43 - $63.64 $22.6 Million - $25 Million	-393,156 Reduced 9.59%	3,706,656 $223 Million
Q2 2020 Aug 12, 2020	SELL	$54.82 - $64.09 $36.5 Million - $42.7 Million	-666,595 Reduced 13.99%	4,099,812 $241 Million
Q1 2020 May 04, 2020	SELL	$46.4 - $67.43 $81.1 Million - $118 Million	-1,746,897 Reduced 26.82%	4,766,407 $266 Million
Q4 2019 Feb 05, 2020	SELL	$49.21 - $64.19 $81 Million - $106 Million	-1,646,119 Reduced 20.17%	6,513,304 $418 Million
Q3 2019 Nov 08, 2019	BUY	$42.77 - $50.71 $325 Million - $385 Million	7,596,571 Added 1349.66%	8,159,423 $414 Million
Q2 2019 Aug 13, 2019	SELL	$44.62 - $49.34 $496,040 - $548,512	-11,117 Reduced 1.94%	562,852 $25.5 Million
Q1 2019 May 06, 2019	BUY	$45.12 - $53.8 $674,544 - $804,310	14,950 Added 2.67%	573,969 $27.4 Million
Q4 2018 Feb 13, 2019	SELL	$48.76 - $63.23 $143,451 - $186,022	-2,942 Reduced 0.52%	559,019 $29.1 Million
Q3 2018 Nov 09, 2018	BUY	$55.19 - $62.25 $1.01 Million - $1.14 Million	18,256 Added 3.36%	561,961 $34.9 Million
Q2 2018 Aug 08, 2018	SELL	$50.53 - $62.98 $42,394 - $52,840	-839 Reduced 0.15%	543,705 $30.1 Million
Q1 2018 May 07, 2018	BUY	$59.92 - $68.98 $757,209 - $871,700	12,637 Added 2.38%	544,544 $34.4 Million
Q4 2017 Feb 09, 2018	BUY	$59.94 - $65.35 $1.54 Million - $1.68 Million	25,634 Added 5.06%	531,907 $32.6 Million
Q3 2017 Nov 09, 2017	BUY	$55.23 - $63.74 $28 Million - $32.3 Million	506,273	506,273 $32.3 Million

Others Institutions Holding BMY

# of Institutions

2,533

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

Vanguard Group Inc Valley Forge, PA

189M
Shares

$11 Billion
0.18% of portfolio
Black Rock Inc. New York, NY

159M
Shares

$9.24 Billion
0.15% of portfolio
State Street Corp Boston, MA

92.9M
Shares

$5.41 Billion
0.2% of portfolio
Jpmorgan Chase & CO New York, NY

77.9M
Shares

$4.54 Billion
0.33% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

61M
Shares

$3.55 Billion
0.61% of portfolio

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $124B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.

Account